News Formal

Trinity Biotech sells life sciences supply business in $30m deal

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 71%

United States News News

United States United States Latest News,United States United States Headlines

Nasdaq-listed company said life sciences supply is no longer core to its long-term strategy

Trinity Biotech, the Irish-founded medical diagnostics company, has agreed a deal to sell its life sciences supply business to Biosynth for $30 million .

The Nasdaq-listed firm said the deal for its Fitzgerald Industries businesses, is expected to close by the end of the month. Bray-headquartered Trinity develops, manufactures and markets diagnostic systems for the point-of-care and clinical laboratory segments of the diagnostic market. Its products are sold in more than 110 countries, and ...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 8. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Trinity Biotech sells life sciences supply business in $30m dealNasdaq-listed company said life sciences supply is no longer core to its long-term strategy
Source: businessposthq - 🏆 8. / 71 Read more »